Cue Biopharma, Inc. (CUE) is a publicly traded Healthcare sector company. As of May 21, 2026, CUE trades at $20.03 with a market cap of $86.50M and a P/E ratio of -16.45. CUE moved -1.53% today. Year to date, CUE is +77.99%; over the trailing twelve months it is +1.70%. Its 52-week range spans $4.97 to $59.67. Rallies surfaces CUE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded CUE stock?
Rallies tracks politician and congressional stock disclosures for CUE, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Sarraf Pasha bought 4.23K (~$1.31K) on Dec 30, 2025.
Sarraf Pasha bought 77.15K (~$23.17K) on Dec 30, 2025.
Sarraf Pasha bought 86.95K (~$27.60K) on Dec 30, 2025.
CUE Analyst Consensus
CUE analyst coverage data. Average price target: $0.00.
Common questions about CUE
Which politicians traded CUE stock?
Rallies tracks politician and congressional stock disclosures for CUE, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in CUE?
Yes. Rallies tracks politician and congressional stock disclosures for CUE, including reported purchases, sales, dates, owners, and trade amounts when available.
Is CUE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CUE. It does not provide personalized investment advice.
